In September, an FDA advisory committee voted in support of the Galleri multicancer early detection test, the first to reach this stage. Now oncologists need to prepare for the patient questions to follow. Dr. Michael LaPelusa has more for #ASCODailyNews: https://bit.ly/4xScPPJ

Drs. Sumanta Pal of @cityofhope.bsky.social, Marc Braunstein of Perlmutter Cancer Center, and Rahul Banerjee of Fred Hutch Cancer Center discuss CAR T cells, bispecific antibodies and the new era of multiple myeloma care on the latest episode of the #ASCODailyNews Podcast: https://bit.ly/46OHFxR

FDA approval of post-surgery #pembro + belzutifan adds a treatment option for patients with higher-risk #ccRCC. But does it change practice? Read more from Dr. Stepan M. Esagian, Dr. Pavlos Msaouel, and Dr. Andrew W. Hahn for #ASCODailyNews: https://bit.ly/4ABHaF2

ADCs have demonstrated impressive clinical activity across multiple gynecologic malignancies, but they have both risks & benefits as maintenance therapy. Read more from Dr. Premal Thaker & Dr. Joshua Brill of @washumedicine.bsky.social for #ASCODailyNews: https://bit.ly/4dICvHh

Dr. Sumanta Pal of @cityofhope.bsky.social and pioneering investigator Dr. Jedd Wolchok of Weill Cornell Medicine discuss the remarkable evolution in melanoma treatments on the latest episode of the #ASCODailyNews Podcast: https://bit.ly/3SzPqnW